Efficacy of β blockers in patients with heart failure plus atrial fibrillation: An individual-patient data meta-analysis

Efficacy of β blockers in patients with heart failure plus atrial fibrillation: An individual-patient data meta-analysis

Show other versions (1)

Background Atrial fibrillation and heart failure often coexist, causing substantial cardiovascular morbidity and mortality. β blockers are indicated in patients with symptomatic heart failure with reduced ejection fraction; however, the efficacy of these drugs in patients with concomitant atrial fib...

Full description

Bibliographic Details
Main Authors:	Kotecha, D, Holmes, J, Krum, H, Altman, D, Manzano, L, Cleland, J, Lip, G, Coats, A, Andersson, B, Kirchhof, P, Von Lueder, T, Wedel, H, Rosano, G, Shibata, M, Rigby, A, Flather, MD
Format:	Journal article
Language:	English
Published:	Lancet 2014

Similar Items

Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis.
by: Kotecha, D, et al.
Published: (2014)

Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis
by: Kotecha, D, et al.
Published: (2016)

Heart rate, heart rhythm and prognostic benefits of beta-blockers in heart failure: individual patient-data meta-analysis
by: Kotecha, D, et al.
Published: (2017)

Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials
by: Cleland, J, et al.
Published: (2017)

Individual patient data meta-analysis of beta-blockers in heart failure: rationale and design.
by: Kotecha, D, et al.
Published: (2013)

Reply: An incomplete story
by: Cleland, JGF, et al.
Published: (2018)

A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURE
by: G. Savarese, et al.
Published: (2015-09-01)

A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURE
by: G. Savarese, et al.
Published: (2015-09-01)

Peripheral arterial waveforms for the prediction of death and MI: carotid versus radial pulse wave analysis
by: Kotecha, D, et al.
Published: (2013)

Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.
by: McMurray, J, et al.
Published: (2005)

THE ROLE OF VASODILATING BETA-BLOCKERS IN PATIENTS WITH HYPERTENSION AND THE CARDIOMETABOLIC SYNDROME
by: A. A. Taylor, et al.
Published: (2011-08-01)

Early prophylaxis of cardiomyopathy with beta-blockers and angiotensin receptor blockers in patients with Duchenne muscular dystrophy
by: Heirim Lee, et al.
Published: (2022-10-01)

The role of vasodilating β-blockers in patients with complicated hypertension: focus on nebivolol
by: T. D. Giles
Published: (2011-12-01)

Perioperative use of β-blockers in oncological patients
by: П. П. Сорочан, et al.
Published: (2021-03-01)

Beta-blockers, and real clinical practice in Russia: the gap between the understanding of the doses of beta-blockers and subsequent prognosis in patients with cardiovascular disease
by: I V Fomin, et al.
Published: (2017-12-01)

Beta-blockers, and real clinical practice in Russia: the gap between the understanding of the doses of beta-blockers and subsequent prognosis in patients with cardiovascular disease
by: Fomin I.V., et al.
Published: (2017-09-01)

Foreword
by: Andrew JS Coats, et al.
Published: (2019-11-01)

Foreword
by: Andrew JS Coats, et al.
Published: (2019-05-01)

Foreword
by: Andrew JS Coats, et al.
Published: (2019-01-01)

Erratum to: Foreword
by: Andrew JS Coats, et al.
Published: (2019-01-01)

Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study.
by: Shen, L, et al.
Published: (2013)

Do Diuretics, Beta-Blockers, and Statins Increase the Risk of Diabetes in Patients with Impaired Glucose Tolerance? Insights from the NAVIGATOR Study
by: Shen, L, et al.
Published: (2012)

Possibilities of Combination of Beta-blockers and Ivabradine in Patients with Stable Angina Pectoris
by: V. V. Kashtalap, et al.
Published: (2019-11-01)

Use of Calcium Channel Blockers is Associated with Mortality in Patients with Chronic Kidney Disease
by: Dominik G. Haider, et al.
Published: (2015-12-01)

COMBINED ANTIHYPERTENSIVE THERAPY: ACE INHIBITOR PLUS CALCIUM CHANNEL BLOCKER. NEW ADVANTAGES OF THE KNOWN COMBINATION
by: S. A. Boitsov, et al.
Published: (2016-01-01)

Beta-blocker use in patients with heart failure with preserved ejection fraction and sinus rhythm
by: Francesc Formiga, et al.
Published: (2022-10-01)

Angiotensin receptor blockers and β-blockers in Marfan syndrome: an individual-patient-data meta-analysis of randomised trials
by: Pitcher, A, et al.
Published: (2022)

Beta-blockers after myocardial infarction: Are they useful to all patients? And how long should be the beta-blocker therapy?
by: Roberto F.E. Pedretti
Published: (2018-06-01)

The cardioprotective role of beta-blockers in patients with diabetes mellitus.
by: Landray, M, et al.
Published: (2002)

The Role of Neuroglia in Administrating Nerve Blockers and Anesthesia to Patients
by: Anjali Patel, et al.
Published: (2024-01-01)

Current Knowledge of Beta-Blockers in Chronic Hemodialysis Patients
by: Haddiya I, et al.
Published: (2023-10-01)

Beta-blockers in patients with liver cirrhosis: Pragmatism or perfection?
by: Tilman Sauerbruch, et al.
Published: (2023-01-01)

Beta-Blockers and Oxidative Stress in Patients with Heart Failure
by: Kazufumi Nakamura, et al.
Published: (2011-08-01)

Beta-blockers in chronic heart failure in elderly patient
by: Alberto De Bernardi
Published: (2009-06-01)

Benefit of ivabradine combined with beta-blocker in comparison with increased dose of beta-blocker in stable angina
by: T. De, et al.
Published: (2014-11-01)

Use of Angiotensin Receptor Blockers in Combination Therapy of Patients with Essential Hypertension and Diabetes Mellitus
by: M.D. Ivanova, et al.
Published: (2015-04-01)

Beta-blocker therapy of cardiovascular diseases in patients with bronchial asthma or COPD: the pro viewpoint.
by: Ashrafian, H, et al.
Published: (2005)

β-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure
by: G. Ambrosio, et al.
Published: (2011-08-01)

Current and future use of angiotensin II receptor blockers in patients with COVID-19
by: A. V. Matveev, et al.
Published: (2020-10-01)

Leukocyte redistribution: effects of beta blockers in patients with chronic heart failure.
by: Stephan von Haehling, et al.
Published: (2009-07-01)